BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

CU Medicine Innovates MOZAICTM Microbiome Tech for Fecal Microbiota Transplants

Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up...

November 17, 2023 | News

SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023

Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...

November 14, 2023 | News

Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA

The R&D Center will focus on advancing molecular diagnostic technologies and novel therapeutic platforms. Situated at the heart of the burgeoning biote...

November 13, 2023 | News

Cromatic closes $5.3 million in oversubscribed seed round to modernize life science R&D outsourcing

Cromatic, a full-stack digital platform for outsourced life sciences research, announced it has closed $5.3 million in funding. LifeX Ventures ...

November 10, 2023 | News

PharmAbcine Advances PMC-403 Clinical Trial in South Korea for Macular Degeneration

Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...

November 10, 2023 | News

DiscGenics Collaborates with U.S. Department of Veterans Affairs on Tissue-Engineered Discs

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate p...

November 10, 2023 | News

Genome Insight Secures $23 Million in Series B-2 Funding Round

This investment will support Genome Insight’s pursuit of bringing whole-genome based precision diagnostics to routine clinical care. Earlier this yea...

November 03, 2023 | News

AusBiotech 2023 kicks off in Brisbane with 1,200 delegates representing global life science ecosystem

Held in Brisbane from 1-3 November, Australia’s biggest week in biotech features its flagship event, AusBiotech 2023, which today launches with more ...

November 01, 2023 | News

AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech

Australia’s biggest week is officially underway, with AusBioInvest 2023 kicking off today in Melbourne to an audience of investors and life sci...

October 30, 2023 | News

Endeavor BioMedicines Licenses HER3-Targeted ADC Worldwide Rights from Hummingbird Bioscience

Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hum...

October 20, 2023 | News

WuXi XDC and HKSTP Collaborate to Boost Bioconjugate Drug Industry in Hong Kong

Hong Kong Science and Technology Parks Corporation (HKSTPC) and WuXi XDC signed a cooperation framework agreement to jointly promote ...

October 18, 2023 | News

ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration

ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...

October 13, 2023 | News

Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio

First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...

October 13, 2023 | News

MediLink and BioNTech Partner for Advanced Anti-Cancer Drug

Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...

October 13, 2023 | News

Stay Connected